MXPA05002465A - Tratamiento del cancer de mama metastatico con antraciclinas y taxanos. - Google Patents
Tratamiento del cancer de mama metastatico con antraciclinas y taxanos.Info
- Publication number
- MXPA05002465A MXPA05002465A MXPA05002465A MXPA05002465A MXPA05002465A MX PA05002465 A MXPA05002465 A MX PA05002465A MX PA05002465 A MXPA05002465 A MX PA05002465A MX PA05002465 A MXPA05002465 A MX PA05002465A MX PA05002465 A MXPA05002465 A MX PA05002465A
- Authority
- MX
- Mexico
- Prior art keywords
- breast cancer
- metastatic breast
- treatment
- anthracyclines
- taxanes
- Prior art date
Links
- 206010055113 Breast cancer metastatic Diseases 0.000 title abstract 2
- 229940123237 Taxane Drugs 0.000 title abstract 2
- 229940045799 anthracyclines and related substance Drugs 0.000 title abstract 2
- 239000000739 antihistaminic agent Substances 0.000 title 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 3
- 229940127089 cytotoxic agent Drugs 0.000 abstract 3
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 abstract 2
- 102000000543 Histamine Receptors Human genes 0.000 abstract 1
- 108010002059 Histamine Receptors Proteins 0.000 abstract 1
- 238000009098 adjuvant therapy Methods 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 235000010290 biphenyl Nutrition 0.000 abstract 1
- 239000004305 biphenyl Substances 0.000 abstract 1
- -1 diphenyl compound Chemical class 0.000 abstract 1
- 229960001340 histamine Drugs 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40767902P | 2002-09-04 | 2002-09-04 | |
| PCT/CA2003/001340 WO2004022040A2 (en) | 2002-09-04 | 2003-09-03 | Treatment of metastatic breast cancer with anthracyclines, taxanes and an histamine antagonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05002465A true MXPA05002465A (es) | 2005-12-14 |
Family
ID=31978506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05002465A MXPA05002465A (es) | 2002-09-04 | 2003-09-03 | Tratamiento del cancer de mama metastatico con antraciclinas y taxanos. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20060089317A1 (https=) |
| EP (1) | EP1536779A2 (https=) |
| JP (1) | JP2006516533A (https=) |
| KR (1) | KR20050086415A (https=) |
| CN (1) | CN1694691A (https=) |
| AU (1) | AU2003266047A1 (https=) |
| BR (1) | BR0314097A (https=) |
| CA (1) | CA2497180A1 (https=) |
| MX (1) | MXPA05002465A (https=) |
| RU (1) | RU2005109421A (https=) |
| WO (1) | WO2004022040A2 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2063574T3 (es) * | 1990-12-17 | 1995-01-01 | Univ Manitoba | Metodo de tratamiento mejorado para el cancer. |
| GB9303210D0 (en) * | 1993-02-17 | 1993-03-31 | Univ Manitoba | Cancer treatment |
| PL369792A1 (en) * | 2001-11-01 | 2005-05-02 | Ym Biosciences, Inc. | Use of n,n-diethyl-2-[-4-(phenylmethyl)-phenoxy]ethanamine monohydrochloride (dppe) in cancer therapy |
| US20050119263A1 (en) * | 2001-11-09 | 2005-06-02 | Vincent Mark D. | Treatment of breast cancer |
-
2003
- 2003-09-03 CA CA002497180A patent/CA2497180A1/en not_active Abandoned
- 2003-09-03 JP JP2004533120A patent/JP2006516533A/ja not_active Withdrawn
- 2003-09-03 CN CNA038247461A patent/CN1694691A/zh active Pending
- 2003-09-03 AU AU2003266047A patent/AU2003266047A1/en not_active Abandoned
- 2003-09-03 WO PCT/CA2003/001340 patent/WO2004022040A2/en not_active Ceased
- 2003-09-03 US US10/526,563 patent/US20060089317A1/en not_active Abandoned
- 2003-09-03 MX MXPA05002465A patent/MXPA05002465A/es unknown
- 2003-09-03 KR KR1020057003797A patent/KR20050086415A/ko not_active Ceased
- 2003-09-03 BR BR0314097-0A patent/BR0314097A/pt not_active IP Right Cessation
- 2003-09-03 RU RU2005109421/14A patent/RU2005109421A/ru not_active Application Discontinuation
- 2003-09-03 EP EP03793535A patent/EP1536779A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1536779A2 (en) | 2005-06-08 |
| KR20050086415A (ko) | 2005-08-30 |
| JP2006516533A (ja) | 2006-07-06 |
| AU2003266047A8 (en) | 2004-03-29 |
| WO2004022040A2 (en) | 2004-03-18 |
| BR0314097A (pt) | 2005-07-19 |
| CN1694691A (zh) | 2005-11-09 |
| AU2003266047A1 (en) | 2004-03-29 |
| CA2497180A1 (en) | 2004-03-18 |
| RU2005109421A (ru) | 2005-10-20 |
| WO2004022040A3 (en) | 2004-04-29 |
| US20060089317A1 (en) | 2006-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2004136984A (ru) | Применение доцетаксела/доксорубицина/циклофосфамида во вспомогательной терапии рака молочной железы и яичников | |
| RU2400232C2 (ru) | Комбинации терапевтических агентов для лечения рака | |
| NO20072543L (no) | Anti-cancer-behandling | |
| AR079256A1 (es) | Metodo para el tratamiento del cancer de mama metastasico con trastuzumab-mcc-dm1 | |
| NZ544472A (en) | Compounds and therapeutical use thereof | |
| MXPA03010121A (es) | Terapia de combinacion que utiliza anticuerpos anti-receptor de factor de crecimiento epidermico y agentes anti-hormonales. | |
| JP2006503919A5 (https=) | ||
| WO2004045532A3 (en) | Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis | |
| WO2005044307A3 (en) | Methods of therapy for b cell-related cancers | |
| BG108072A (en) | The use of epothilone derivatives for the treatment of refractory tumors | |
| ATE361746T1 (de) | Botanischer extrakt mit antikrebs-aktivität enthaltend isoliquiritigenin | |
| WO2005000204A3 (en) | Pancreatic cancer treatment | |
| MXPA05002465A (es) | Tratamiento del cancer de mama metastatico con antraciclinas y taxanos. | |
| TW200633700A (en) | Methods of using temozolomide formulation intrathecally in the treatment of cancers | |
| IL158058A (en) | Combination of a taxane and a cyclin-dependent kinase inhibitor | |
| MXPA05009849A (es) | Terapia combinada que comprende nemorubicina y un inhibidor de la ciclooxigenasa-2. | |
| GB0326518D0 (en) | Anti-cancer compounds | |
| BR0314253A (pt) | Uso de uma combinação de dppe com outros agentes quimioterápicos para o tratamento de câncer de mama | |
| US20080318880A1 (en) | Neoadjuvant treatment of Breast Cancer | |
| TW200509925A (en) | Method comprising irinotecan for treatment of breast cancer | |
| UA49523A (uk) | Спосіб хіміотерапії раку шийки матки |